AstraZeneca PLC (AZN)

NYSE • Currently down 2.07 (-1.26%) in today's trading session

10 members of Congress have disclosed 31 trades in AstraZeneca PLC (AZN) via STOCK Act filings. The most recent disclosure was a purchase by Gilbert Cisneros on 18 December 2025. The most active traders have been Lisa McClain (6), Bruce Westerman (4), and John H. Rutherford (4). Aggregate disclosed activity totals roughly $136.5K in purchases and $193.5K in sales (midpoint estimates from bracketed disclosure amounts).

AstraZeneca PLC is currently trading at $162.70, positioned at 25% of its 52-week range ($145.80 – $212.71).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Current Price
$162.70
24h Change
-2.07 (-1.26%)
52 Week Range
$145.80–$212.71
View on NASDAQ

AstraZeneca PLC Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for AZN

Select to highlight on chart
5 transactions
Compliance: 65%
Gilbert Cisneros18 Dec 202512 Jan 2026PurchaseStock$1,001 - $15,000-9.47%
Julia Letlow8 Dec 202513 Jan 2026PurchaseStock$1,001 - $15,000-10.88%
Gilbert Cisneros19 Nov 202515 Dec 2025PurchaseStock$1,001 - $15,000-9.16%
Lisa McClain31 Oct 202521 Nov 2025SaleStock$1,001 - $15,000N/A
Lisa McClain30 Oct 202521 Nov 2025SaleStock$1,001 - $15,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$252.33B

Volume

3.07M

Beta

0.21

P/E Ratio

17.57

Fundamentals

EPS

$9.26

Div. Yield

1.99%

Open

$162.82

Day Range

$161.13 – $163.78

Company Information

Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYSE · USD
Country
GB
CEO
Pascal Claude Roland Soriot
IPO Date
1993-05-12
Website
www.astrazeneca.com

AstraZeneca PLC operates as a global biopharmaceutical leader, dedicated to the entire process of bringing prescription medicines to market, from their initial discovery and development through manufacturing and commercialization. The company's exten...

Earnings

Next Report

Q3 2026

30 Oct

EPS Est.

$2.60

Rev. Est.

$16B

Days Until

53

Recent Quarters

Q2 202627 Jul
EPS$2.63
Beat 5.2%
Q1 202629 Apr
EPS$2.58
Beat 0.4%
Q4 202510 Feb
EPS$2.12
Beat 1.4%
Q3 20256 Nov
EPS$2.38
Beat 4.4%
Q2 202529 Jul
EPS$2.18
Beat 0.0%
Q1 202529 Apr
EPS$2.48
Beat 12.7%
Q4 20246 Feb
EPS$2.10
Beat 1.4%
Q3 202412 Nov
EPS$2.08
Beat 3.0%
Q2 202425 Jul
EPS$1.98
Beat 3.1%
Q1 202425 Apr
EPS$2.06
Beat 8.4%
Q4 20238 Feb
EPS$1.46
Miss 1.4%
Q3 20239 Nov
EPS$0.86
Beat 2.6%
Q2 202328 Jul
EPS$1.08
Beat 9.3%
Q1 202327 Apr
EPS$1.16
Beat 8.4%
Q4 20229 Feb
EPS$0.69
Beat 2.7%
Q3 202210 Nov
EPS$0.84
Beat 10.8%
Q2 202229 Jul
EPS$0.86
Beat 9.8%
Q1 202229 Apr
EPS$1.90
Beat 120.9%
Q4 202110 Feb
EPS$1.68
Beat 118.2%
Q3 202112 Nov
EPS$1.08
Beat 71.4%
Q2 202129 Jul
EPS$0.90
Beat 100.0%
Q1 202130 Apr
EPS$1.62
Beat 116.0%
Q4 202011 Feb
EPS$1.08
Beat 1.9%
Q3 20205 Nov
EPS$0.94
Miss 4.1%
Q2 202030 Jul
EPS$0.96
Beat 110.9%
Q1 202029 Apr
EPS$1.06
Beat 125.5%
Q4 201914 Feb
EPS$0.48
Miss 54.7%
Q3 201924 Oct
EPS$0.50
Beat 4.8%
Q2 201925 Jul
EPS$0.74
Beat 146.7%
Q1 201926 Apr
EPS$0.90
Beat 112.6%
Q4 201814 Feb
EPS$1.58
Beat 107.9%
Q3 20188 Nov
EPS$0.72
Beat 60.0%
Q2 201826 Jul
EPS$0.70
Beat 133.3%
Q1 201818 May
EPS$0.48
Miss 14.3%
Q4 20172 Feb
EPS$1.30
Beat 44.4%
Q3 20179 Nov
EPS$1.12
Beat 103.6%
Q2 201727 Jul
EPS$0.88
Beat 109.5%
Q1 201727 Apr
EPS$1.00
Beat 31.6%
Q4 20162 Feb
EPS$1.22
Beat 106.8%
Q3 201610 Nov
EPS$1.32
Beat 37.5%
Q2 201628 Jul
EPS$0.83
Beat 9.2%
Q1 201629 Apr
EPS$0.96
Beat 100.0%
Q4 20154 Feb
EPS$0.94
Beat 113.6%
Q3 20155 Nov
EPS$1.02
Beat 0.0%
Q2 201530 Jul
EPS$1.22
Beat 17.3%
Q1 201524 Apr
EPS$1.08
Beat 103.8%
Q4 20145 Feb
EPS$0.76
Beat 58.3%
Q3 20146 Nov
EPS$1.05
Beat 101.9%
Q2 201431 Jul
EPS$1.30
Beat 15.0%
Q1 201424 Apr
EPS$1.17
Beat 80.0%
Q4 20136 Feb
EPS$1.23
Beat 101.6%
Q3 201331 Oct
EPS$1.21
Beat 86.2%
Q2 20131 Aug
EPS$1.20
Beat 106.9%
Q1 201325 Apr
EPS$1.41
Beat 110.5%
Q4 201231 Jan
EPS$1.72
Beat 24.6%
Q3 201225 Oct
EPS$1.51
Beat 104.0%
Q2 201226 Jul
EPS$0.77
Beat 13.2%
Q1 201226 Apr
EPS$0.91
Beat 2.3%
Q4 20116 Feb
EPS$0.81
Beat 3.9%
Q3 201127 Oct
EPS$0.86
Beat 2.4%
Q2 201128 Jul
EPS$0.87
Miss 4.4%
Q1 201128 Apr
EPS$1.12
Beat 3.7%
Q4 201027 Jan
EPS$0.70
Beat 4.5%
Q3 201028 Oct
EPS$0.75
Beat 0.0%
Q2 201029 Jul
EPS$0.90
Beat 12.5%
Q1 201029 Apr
EPS$1.01
Beat 17.4%
Q4 200928 Jan
EPS$0.71
Miss 6.6%
Q3 200929 Oct
EPS$0.84
Beat 21.7%
Q2 200930 Jul
EPS$0.82
Beat 17.1%
Q1 200930 Apr
EPS$0.79
Beat 12.9%
Q4 200829 Jan
EPS$0.63
Beat 8.6%
Q3 200830 Oct
EPS$0.66
Beat 15.8%
Q2 200831 Jul
EPS$0.63
Beat 16.7%
Q1 200824 Apr
EPS$0.64
Beat 6.7%
Q4 200731 Jan
EPS$0.55
Beat 17.0%
Q3 20071 Nov
EPS$0.52
Beat 13.0%
Q2 200726 Jul
EPS$0.60
Beat 15.4%
Q1 200723 Apr
EPS$0.51
Beat 0.0%
Q4 20061 Feb
EPS$0.47
Miss 2.1%
Q3 200626 Oct
EPS$0.51
Beat 4.1%
Q2 200627 Jul
EPS$0.51
Beat 8.5%
Q1 200627 Apr
EPS$0.45
Beat 12.5%
Q4 20052 Feb
EPS$0.39
Beat 5.4%
Q3 200527 Oct
EPS$0.38
Beat 15.2%
Q2 200528 Jul
EPS$0.38
Beat 35.7%
Q1 200528 Apr
EPS$0.32
Beat 10.3%
Q4 200428 Jan
EPS$0.30
Beat 3.5%
Q3 200425 Oct
EPS$0.28
Beat 7.7%
Q2 200422 Jul
EPS$0.25
Beat 4.2%
Q1 200429 Apr
EPS$0.24
Miss 11.1%
Q4 200329 Jan
EPS$0.19
Miss 5.0%
Q3 200323 Oct
EPS$0.24
Beat 41.2%
Q2 200324 Jul
EPS$0.20
Beat 17.6%
Q1 200330 Apr
EPS$0.27
Beat 28.6%
Q4 200230 Jan
EPS$0.23
Beat 9.5%
Q3 200224 Oct
EPS$0.20
Beat 11.1%
Q2 200225 Jul
EPS$0.23
Miss 4.2%
Q1 200226 Apr
EPS$0.28
Beat 16.7%
Q4 200131 Jan
EPS$0.89
Beat 287.0%
Q3 200124 Oct
EPS$0.24
Beat 14.3%
Q2 200126 Jul
EPS$0.21
Beat 0.0%
Q4 20008 Feb
EPS$0.21
Beat 0.0%
Q3 200025 Oct
EPS$0.19
Miss 17.4%
Q4 199925 Feb
EPS$-0.20
Miss 209.0%
Q3 199929 Oct
EPS$0.19
Beat 11.8%
Q2 19999 Aug
EPS$0.41
Beat 70.8%
Q4 199817 Feb
EPS$0.25
Beat 4.2%
Q4 199621 Mar
EPS$1.34
Beat 458.3%

13 politicians traded within 30 days

Dividends

Dividend History

7 Aug 2026
Amount $1.0600
20 Feb 2026
Amount $2.1700
8 Aug 2025
Amount $1.0300
21 Feb 2025
Amount $2.1281
9 Aug 2024
Amount $1.0000
22 Feb 2024
Amount $1.9700
10 Aug 2023
Amount $0.9300
23 Feb 2023
Amount $1.9700
11 Aug 2022
Amount $0.9318
24 Feb 2022
Amount $1.9700
12 Aug 2021
Amount $0.8965
25 Feb 2021
Amount $1.9418
13 Aug 2020
Amount $0.9114
27 Feb 2020
Amount $1.8847
8 Aug 2019
Amount $0.8724
28 Feb 2019
Amount $1.9000
9 Aug 2018
Amount $0.9000
15 Feb 2018
Amount $1.9000
9 Aug 2017
Amount $0.9000
15 Feb 2017
Amount $1.9000
10 Aug 2016
Amount $0.9000
17 Feb 2016
Amount $1.9000
12 Aug 2015
Amount $0.9000
18 Feb 2015
Amount $1.9000
13 Aug 2014
Amount $0.9000
19 Feb 2014
Amount $1.9000
14 Aug 2013
Amount $0.9000
13 Feb 2013
Amount $1.9000
8 Aug 2012
Amount $0.9000
15 Feb 2012
Amount $1.9500
4 Aug 2011
Amount $0.8500
2 Feb 2011
Amount $1.8500
4 Aug 2010
Amount $0.7000
3 Feb 2010
Amount $1.7100
5 Aug 2009
Amount $0.5900
4 Feb 2009
Amount $1.5000
6 Aug 2008
Amount $0.5500
7 Feb 2008
Amount $1.3500
8 Aug 2007
Amount $0.5200
7 Feb 2007
Amount $1.2300
9 Aug 2006
Amount $0.4900
8 Feb 2006
Amount $0.9200
10 Aug 2005
Amount $0.3800
9 Feb 2005
Amount $0.6450
11 Aug 2004
Amount $0.2950
18 Feb 2004
Amount $0.5400
20 Aug 2003
Amount $0.2550
19 Feb 2003
Amount $0.5222
21 Aug 2002
Amount $0.2556
20 Feb 2002
Amount $0.5222
22 Aug 2001
Amount $0.2555
21 Feb 2001
Amount $0.5222
14 Nov 2000
Amount $1.0730
6 Sept 2000
Amount $0.2555
8 Mar 2000
Amount $0.5222
8 Sept 1999
Amount $0.2555
7 Apr 1999
Amount $0.4956
16 Sept 1998
Amount $0.2830
18 Mar 1998
Amount $0.5120
17 Sept 1997
Amount $0.2663
19 Mar 1997
Amount $0.4473
20 Sept 1996
Amount $0.2407
22 Mar 1996
Amount $0.2533
22 Sept 1995
Amount $0.2237
24 Mar 1995
Amount $0.3507
23 Sept 1994
Amount $0.2053
18 Mar 1994
Amount $0.3143
24 Sept 1993
Amount $0.1930

Stock Splits

Split History

2 Feb 2026Reverse Split
Ratio1:2
27 Jul 2015Stock Split
Ratio2:1
8 Apr 1998Stock Split
Ratio3:1

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

JNJ

Johnson & Johnson

66
$275.23-3.20 (-1.15%)
Healthcare
3 politicians hold this stock
Same sector: Healthcare
3 politicians
View Stock

TSM

Taiwan Semiconductor Manufacturing Company Limited

51
$428.91+11.90 (+2.85%)
Technology
4 politicians hold this stock
Significant holdings value
4 politicians
View Stock

JPM

JPMorgan Chase & Co.

51
$358.64-3.42 (-0.94%)
Financial Services
4 politicians hold this stock
Significant holdings value
4 politicians
View Stock

Frequently Asked Questions about AZN

Which members of Congress have traded AZN?
10 members of Congress have disclosed 31 trades in AstraZeneca PLC (AZN) under the STOCK Act. The most active traders are Lisa McClain, Bruce Westerman, and John H. Rutherford.
When was AZN most recently disclosed by Congress?
The most recent AZN disclosure was a purchase by Gilbert Cisneros on 18 December 2025.
What is the total disclosed congressional trading volume for AZN?
Members of Congress have disclosed approximately $136.5K in AZN purchases and $193.5K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in AZN?
This AZN page updates as soon as new STOCK Act disclosures are filed for AstraZeneca PLC. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.